These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8393944)

  • 1. Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors.
    Moul JW; Foley JP; Hitchcock CL; McCarthy WF; Sesterhenn IA; Becker RL; Griffin JL
    J Urol; 1993 Sep; 150(3):879-83. PubMed ID: 8393944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of P53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease.
    Lewis DJ; Sesterhenn IA; McCarthy WF; Moul JW
    J Urol; 1994 Aug; 152(2 Pt 1):418-23. PubMed ID: 8015085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors.
    Fernandez EB; Sesterhenn IA; McCarthy WF; Mostofi FK; Moul JW
    J Urol; 1994 Oct; 152(4):1133-8. PubMed ID: 7915335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer.
    Spermon JR; De Wilde PC; Hanselaar AG; Schaafsma HE; Ruijter TE; Witjes JA; Van Moorselaar RJ
    BJU Int; 2002 Feb; 89(3):278-84. PubMed ID: 11856111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric DNA ploidy pattern for predicting metastasis of clinical stage I nonseminomatous germ cell testicular tumors.
    Austenfeld MS; Bilhartz DL; Nativ O; Farrow GM; Lieber MM
    Urology; 1993 Apr; 41(4):379-83. PubMed ID: 8385834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors.
    De Riese WT; De Riese C; Ulbright TM; Walker EB; Messemer J; Jones JA; Reister T; Albers P; Allhoff EP; Foster RS
    Int J Cancer; 1994 Jun; 57(5):628-33. PubMed ID: 8194868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors.
    Heidenreich A; Schenkmann NS; Sesterhenn IA; Mostofi FK; McCarthy WF; Heidenreich B; Moul JW
    J Urol; 1997 Aug; 158(2):620-5. PubMed ID: 9224380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New parameters for prediction of pathological stage in clinical stage I non-seminomatous testicular tumors].
    Albers P; Ulbright TM; Albers J; Miller GA; Foster RS; Donohue JP
    Urologe A; 1995 Jul; 34(4):316-23. PubMed ID: 7676541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy in the primary tumor from patients with nonseminomatous testicular germ cell tumors clinical stage I.
    Fosså SD; Nesland JM; Waehre H; Amellem O; Pettersen EO
    Cancer; 1991 Apr; 67(7):1874-7. PubMed ID: 1848470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on nuclear DNA content in testicular germ cell tumors using flow cytometry].
    Kashiwagi A
    Hokkaido Igaku Zasshi; 1992 Nov; 67(6):801-14. PubMed ID: 1336479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.
    Moul JW; McCarthy WF; Fernandez EB; Sesterhenn IA
    Cancer Res; 1994 Jan; 54(2):362-4. PubMed ID: 8275469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.
    Albers P; Ulbright TM; Albers J; Miller GA; Orazi A; Crabtree WN; Baniel J; Reister T; Sidner RA; Foster RS; Donohue JP
    J Urol; 1996 Feb; 155(2):579-86. PubMed ID: 8558664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors.
    de Riese W; Walker EB; de Riese C; Ulbright TM; Crabtree WN; Messemer J; Jones JA; Hinkel A; Foster RS; Donohue JP
    Urol Res; 1994; 22(4):213-20. PubMed ID: 7871632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonseminomatous germ cell tumor of the testicle: does extensive staging of the primary tumor predict the likelihood of metastatic disease?
    Rodriguez PN; Hafez GR; Messing EM
    J Urol; 1986 Sep; 136(3):604-8. PubMed ID: 3016346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors.
    de Riese WT; Albers P; Walker EB; Ulbright TM; Crabtree WN; Reister T; Foster RS; Donohue JP
    Cancer; 1994 Aug; 74(4):1335-41. PubMed ID: 8055457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of aneuploid stemlines in testicular nonseminomatous germ cell tumors.
    de Graaff WE; Sleijfer DT; de Jong B; Dam A; Schraffordt Koops H; Oosterhuis JW
    Cancer; 1993 Aug; 72(4):1300-4. PubMed ID: 8393372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric analysis of DNA content in adult testicular germ cell tumors].
    Kashiwagi A; Nagamori S; Nonomura K; Toyota K; Koyanagi T; Nojima T; Inoue K
    Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1062-70. PubMed ID: 1324379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
    Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
    Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
    Albers P; Miller GA; Orazi A; Ulbright TM; Albers J; Donohue JP; Foster RS
    Cancer; 1995 Feb; 75(3):844-50. PubMed ID: 7828136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
    Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
    J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.